HarNeedi - Healthcare & Pharma Job Portal

Healthcare & Pharma Articles

Pharmaceutical companies Tagged Posts

Benefits from Digital health technologies for Pharma

India is the biggest manufacturer and exporter of generic drugs on globe and considered as the pharmacy of the globe. However many Indian pharma companies find it difficult to survive in global markets due to the heavy competition, lack of market research knowledge, complex regulatory results and not embracing the latest digital technologies adopted by global companies.

Innovation brings both opportunity and change, and this is true with emerging point of care technology. There is a pressing need for help in the three critical areas of Prevention, Diagnosis and Monitoring.But extremely restrictive regulations, the presence of multiple key stakeholders, a slow-to-adopt culture and other challenges distinguish healthcare from the retail and finance sectors, which have flourished with their implementations of digital technologies. 

Continue Reading @ http://bit.ly/2L3Zm0O

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

Focus on skilled talent pipeline in Indian Pharma sector

In recent years, several domestic pharmaceutical companies from India has addressed their recruitment needs to flourish their footprint extensively in international pharmaceutical arena and to improve quality of output.

Simultaneously various multinational companies are planing for job cuts, the enticed international market, is making companies in India and other Asian parts strengthen the quality of their human resource base. Now the evolution of human capital is one of the most vital factor for the companies growth, re-structuring of management training programs to built a highly motivated, innovative, and ethically committed team(s) to play a key role in ensuring the future pharma industry progress. The various schemes such as fortifying quality manpower is now an integrated part of the agenda of Asian pharmaceutical companies, as the aim is the evolution of new and innovative drugs.

Continue Reading @ https://bit.ly/2jWcFEB

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

Pharmaceutical Clinical Data Management

Clinical Data Management and CDISC standards:

Many pharmaceutical and biotechnology companies are working on the development of new drugs, compounds and devices for betterment of human health and increase the quality of life globally. This process of drug development and discovery when reaches the stage of testing in human volunteers involves people from various specialty and varied background. Final goal of any human trial is to be able to investigate the safety and efficacy of the investigative compound or device in human subjects within the regulatory guidelines and accepted standards of safety, patient care and data interpretation.

The initial stage of any clinical study involves the collection of observational, laboratory and other data of the trail subjects and is the most critical part in the study life cycle. It is this collected data, which will be used in analyzes of final end points of any study. The quality of data and accuracy then becomes most important thing. The great

continue reading
2 readers |0 Comments|Reply

Generics Revolutionizing the Indian Healthcare Industries

Revolutionary Effect of Generics In Healthcare Industry:

The Indian pharma industry traces back its origin to 1903 when Bengal Chemical and Pharmaceutical Works was initiated in Calcutta by Professor P.C. Roy Pre?independent India largely remained dependent on other countries for medicines. The major suppliers were UK, France, and Germany. The new government post-independence focused on self-dependence and emphasized on industrialization that also included pharmaceuticals. As a result Hindustan Antibiotics Ltd. (HAL) came into existence in 1954, and following it was Indian Drugs and Pharmaceuticals Ltd. (IDPL) in 1961.

The IDPL program proved India to be capable of producing drugs at very reasonable prices and also helped in developing human and physical capital, and in establishing a network of research institutes. In spite of these facts, till 1970s the pharma industry in India was dominated by multinational companies (MNCs), which continued minimum physical operations in India.

C

continue reading
2 readers |0 Comments|Reply
[]